Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000517953 | SCV000612790 | uncertain significance | not specified | 2016-12-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001851430 | SCV002158733 | uncertain significance | Congenital myotonia, autosomal recessive form; Congenital myotonia, autosomal dominant form | 2020-12-15 | criteria provided, single submitter | clinical testing | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CLCN1 protein function. This variant has been observed in individual(s) with autosomal dominant myotonia congenita (PMID: 23113340). ClinVar contains an entry for this variant (Variation ID: 447068). This variant is not present in population databases (ExAC no frequency). This sequence change replaces serine with proline at codon 183 of the CLCN1 protein (p.Ser183Pro). The serine residue is moderately conserved and there is a moderate physicochemical difference between serine and proline. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Department of Neurology and Geriatrics, |
RCV002267616 | SCV002549786 | uncertain significance | Congenital myotonia, autosomal dominant form | 2022-04-06 | no assertion criteria provided | research |